Get access to our best features
Get access to our best features
Published 4 months ago

Cipla Unit To Develop Cell Therapy Products In JV With Kemwell, Manipal

Summary by NDTV Profit
A Cipla Ltd. unit will form a joint venture in the U.S. with Kemwell Biopharma Pvt. and Manipal Education and Medical Group to develop and commercialise novel cell therapy products for foreign markets.Cipla (EU) Ltd. U.K., a wholly owned subsidiary, will secure 35.2% stake in the JV, which includes Bengaluru-headquartered Kemwell Biopharma's U.K. unit and Manipal arm MNI Ventures, Mauritius, according to an exchange filing on Monday.The strategi…

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)